Acrivon Therapeutics, Inc 10-Q for FY2022 Q3
Acrivon Therapeutics, Inc. (ACRV)
10-Q
2022-12-15
For: 2022-09-30
View Original
Added on
April 07, 2026
About this 10-Q
Acrivon Therapeutics, Inc filed this 10-Q on December 15, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $9.2M
- compared with a net loss of $2.44M a year earlier
- Diluted EPS
- -$5.17
- compared with -$1.38 a year earlier